{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:00:04Z","timestamp":1771052404822,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-281","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T18:22:45Z","timestamp":1309371765000},"source":"Crossref","is-referenced-by-count":43,"title":["Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL\/KsJ-db\/dbobese mice"],"prefix":"10.1186","volume":"11","author":[{"given":"Masahito","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Terakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"2771_CR1","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007, 132: 2557-2576. 10.1053\/j.gastro.2007.04.061.","journal-title":"Gastroenterology"},{"key":"2771_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","volume":"126","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004, 126: 460-468. 10.1053\/j.gastro.2003.10.065.","journal-title":"Gastroenterology"},{"key":"2771_CR3","first-page":"204","volume":"35","author":"Y Muto","year":"2006","unstructured":"Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y, for the Long-Term Survival Study (LOTUS) Group: Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res. 2006, 35: 204-214.","journal-title":"Hepatol Res"},{"key":"2771_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1872-034X.2009.00616.x","volume":"40","author":"K Imai","year":"2010","unstructured":"Imai K, Takai K, Nishigaki Y, Shimizu S, Naiki T, Hayashi H, Uematsu T, Sugihara J, Tomita E, Shimizu M, Nagaki M, Moriwaki H: Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study. Hepatol Res. 2010, 40: 376-382. 10.1111\/j.1872-034X.2009.00616.x.","journal-title":"Hepatol Res"},{"key":"2771_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20750","volume":"42","author":"EE Powell","year":"2005","unstructured":"Powell EE, Jonsson JR, Clouston AD: Steatosis: co-factor in other liver diseases. Hepatology. 2005, 42: 5-13.","journal-title":"Hepatology"},{"key":"2771_CR6","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1002\/cncr.24687","volume":"115","author":"AB Siegel","year":"2009","unstructured":"Siegel AB, Zhu AX: Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009, 115: 5651-5661. 10.1002\/cncr.24687.","journal-title":"Cancer"},{"key":"2771_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M: Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010, 140: 197-208. 10.1016\/j.cell.2009.12.052.","journal-title":"Cell"},{"key":"2771_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M: Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma. Gastroenterology. 2011, 140: 1071-1083. 10.1053\/j.gastro.2010.12.006.","journal-title":"Gastroenterology"},{"key":"2771_CR9","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010, 51: 1820-1832. 10.1002\/hep.23594.","journal-title":"Hepatology"},{"key":"2771_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.22603","volume":"49","author":"R Vuppalanchi","year":"2009","unstructured":"Vuppalanchi R, Chalasani N: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009, 49: 306-317. 10.1002\/hep.22603.","journal-title":"Hepatology"},{"key":"2771_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278.","journal-title":"Lancet"},{"key":"2771_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.numecd.2007.01.007","volume":"17","author":"P Loria","year":"2007","unstructured":"Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N: Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis. 2007, 17: 684-698. 10.1016\/j.numecd.2007.01.007.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2771_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","volume":"57","author":"H Hyogo","year":"2008","unstructured":"Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K: Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Metabolism. 2008, 57: 1711-1718. 10.1016\/j.metabol.2008.07.030.","journal-title":"Metabolism"},{"key":"2771_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","volume":"47","author":"M Ekstedt","year":"2007","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, Holmqvist M, Bodemar G, Kechagias S: Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol. 2007, 47: 135-141. 10.1016\/j.jhep.2007.02.013.","journal-title":"J Hepatol"},{"key":"2771_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11745-003-1093-x","volume":"38","author":"T Egawa","year":"2003","unstructured":"Egawa T, Toda K, Nemoto Y, Ono M, Akisaw N, Saibara T, Hayashi Y, Hiroi M, Enzan H, Onishi S: Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-\/-) mice. Lipids. 2003, 38: 519-523. 10.1007\/s11745-003-1093-x.","journal-title":"Lipids"},{"key":"2771_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM: Statins and cancer prevention. Nat Rev Cancer. 2005, 5: 930-942. 10.1038\/nrc1751.","journal-title":"Nat Rev Cancer"},{"key":"2771_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jcb.22092","volume":"106","author":"K Gauthaman","year":"2009","unstructured":"Gauthaman K, Fong CY, Bongso A: Statins, stem cells, and cancer. J Cell Biochem. 2009, 106: 975-983. 10.1002\/jcb.22092.","journal-title":"J Cell Biochem"},{"key":"2771_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","volume":"136","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Johnson ML, Hachem C, Morgana RO: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009, 136: 1601-1608. 10.1053\/j.gastro.2009.01.053.","journal-title":"Gastroenterology"},{"key":"2771_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jhep.2005.04.010","volume":"43","author":"AP Sutter","year":"2005","unstructured":"Sutter AP, Maaser K, Hopfner M, Huether A, Schuppan D, Scherubl H: Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor. J Hepatol. 2005, 43: 808-816. 10.1016\/j.jhep.2005.04.010.","journal-title":"J Hepatol"},{"key":"2771_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1248\/bpb.29.634","volume":"29","author":"J Wang","year":"2006","unstructured":"Wang J, Tokoro T, Higa S, Kitajima I: Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells. Biol Pharm Bull. 2006, 29: 634-639. 10.1248\/bpb.29.634.","journal-title":"Biol Pharm Bull"},{"key":"2771_CR21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1349-7006.2010.01579.x","volume":"101","author":"Y Yasuda","year":"2010","unstructured":"Yasuda Y, Shimizu M, Shirakami Y, Sakai H, Kubota M, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H: Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL\/KsJ-db\/db obese mice. Cancer Sci. 2010, 101: 1701-1707. 10.1111\/j.1349-7006.2010.01579.x.","journal-title":"Cancer Sci"},{"key":"2771_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1349-7006.2009.01402.x","volume":"101","author":"J Iwasa","year":"2010","unstructured":"Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H: Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL\/KsJ-db\/db mice. Cancer Sci. 2010, 101: 460-467. 10.1111\/j.1349-7006.2009.01402.x.","journal-title":"Cancer Sci"},{"key":"2771_CR23","first-page":"223","volume-title":"Pathology of Tumors in Laboratory Animals","author":"CH Frith","year":"1994","unstructured":"Frith CH, Ward JM, Turusov VS: Tumours of the liver. Pathology of Tumors in Laboratory Animals. Edited by: Turusor VS, Mohr U. 1994, Lyon: IARC Scientific Publications, 2: 223-270."},{"key":"2771_CR24","first-page":"252","volume":"6","author":"C Grimm","year":"2000","unstructured":"Grimm C, Wenzel A, Hafezi F, Reme CE: Gene expression in the mouse retina: the effect of damaging light. Mol Vis. 2000, 6: 252-260.","journal-title":"Mol Vis"},{"key":"2771_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957, 226: 497-509.","journal-title":"J Biol Chem"},{"key":"2771_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nrm2249","volume":"8","author":"DG Hardie","year":"2007","unstructured":"Hardie DG: AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007, 8: 774-785. 10.1038\/nrm2249.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2771_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford DB, Shaw RJ: The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009, 9: 563-575. 10.1038\/nrc2676.","journal-title":"Nat Rev Cancer"},{"key":"2771_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/mnfr.200800592","volume":"53","author":"CH Huang","year":"2009","unstructured":"Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY, Way TD: EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol Nutr Food Res. 2009, 53: 1156-1165. 10.1002\/mnfr.200800592.","journal-title":"Mol Nutr Food Res"},{"key":"2771_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1940-6207.CAPR-10-0028","volume":"4","author":"N Teraoka","year":"2011","unstructured":"Teraoka N, Mutoh M, Takasu S, Ueno T, Yamamoto M, Sugimura T, Wakabayashi K: Inhibition of intestinal polyp formation by pitavastatin, a HMG-CoA reductase inhibitor. Cancer Prev Res. 2011, 4: 445-453. 10.1158\/1940-6207.CAPR-10-0028.","journal-title":"Cancer Prev Res"},{"key":"2771_CR30","first-page":"904","volume":"47","author":"T Aoki","year":"1997","unstructured":"Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y: Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung. 1997, 47: 904-909.","journal-title":"Arzneimittelforschung"},{"key":"2771_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/01.hyp.0000126186.29571.41","volume":"43","author":"M Sata","year":"2004","unstructured":"Sata M, Nishimatsu H, Osuga J, Tanaka K, Ishizaka N, Ishibashi S, Hirata Y, Nagai R: Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. Hypertension. 2004, 43: 1214-1220. 10.1161\/01.HYP.0000126186.29571.41.","journal-title":"Hypertension"},{"key":"2771_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI109938","volume":"66","author":"T Kita","year":"1980","unstructured":"Kita T, Brown MS, Goldstein JL: Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest. 1980, 66: 1094-1100. 10.1172\/JCI109938.","journal-title":"J Clin Invest"},{"key":"2771_CR33","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/ijc.22976","volume":"121","author":"Y Yasui","year":"2007","unstructured":"Yasui Y, Suzuki R, Miyamoto S, Tsukamoto T, Sugie S, Kohno H, Tanaka T: A lipophilic statin, pitavastatin, suppresses inflammation-associated mouse colon carcinogenesis. Int J Cancer. 2007, 121: 2331-2339. 10.1002\/ijc.22976.","journal-title":"Int J Cancer"},{"key":"2771_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2007-973075","volume":"39","author":"J Hector","year":"2007","unstructured":"Hector J, Schwarzloh B, Goehring J, Strate TG, Hess UF, Deuretzbacher G, Hansen-Algenstaedt N, Beil FU, Algenstaedt P: TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res. 2007, 39: 250-255. 10.1055\/s-2007-973075.","journal-title":"Horm Metab Res"},{"key":"2771_CR35","doi-asserted-by":"publisher","first-page":"R1429","DOI":"10.1152\/ajpregu.00569.2001","volume":"282","author":"BN Finck","year":"2002","unstructured":"Finck BN, Johnson RW: Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol. 2002, 282: R1429-1435.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2771_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K: Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007, 380: 24-30. 10.1016\/j.cca.2007.01.026.","journal-title":"Clin Chim Acta"},{"key":"2771_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ: The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003, 112: 91-100.","journal-title":"J Clin Invest"},{"key":"2771_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jhep.2007.03.020","volume":"47","author":"Y Kamada","year":"2007","unstructured":"Kamada Y, Matsumoto H, Tamura S, Fukushima J, Kiso S, Fukui K, Igura T, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi N: Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol. 2007, 47: 556-564. 10.1016\/j.jhep.2007.03.020.","journal-title":"J Hepatol"},{"key":"2771_CR39","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2010.07.001","volume":"139","author":"NK Saxena","year":"2010","unstructured":"Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, Cohen C, Tighiouart M, Sharma D, Anania FA: Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and inhibits hepatocellular carcinoma. Gastroenterology. 2010, 139: 1762-1773. 10.1053\/j.gastro.2010.07.001.","journal-title":"Gastroenterology"},{"key":"2771_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/hep.22402","volume":"48","author":"CK Argo","year":"2008","unstructured":"Argo CK, Loria P, Caldwell SH, Lonardo A: Statins in liver disease: a molehill, an iceberg, or neither?. Hepatology. 2008, 48: 662-669. 10.1002\/hep.22402.","journal-title":"Hepatology"},{"key":"2771_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","volume":"46","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C: Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol. 2007, 46: 1126-1132. 10.1016\/j.jhep.2007.01.021.","journal-title":"J Hepatol"},{"key":"2771_CR42","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199606133342402","volume":"334","author":"Y Muto","year":"1996","unstructured":"Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med. 1996, 334: 1561-1567. 10.1056\/NEJM199606133342402.","journal-title":"N Engl J Med"},{"key":"2771_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1158\/1940-6207.CAPR-10-0163","volume":"4","author":"M Shimizu","year":"2011","unstructured":"Shimizu M, Sakai H, Shirakami Y, Iwasa J, Yasuda Y, Kubota M, Takai K, Tsurumi H, Tanaka T, Moriwaki H: Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL\/KsJ-db\/db mice. Cancer Prev Res. 2011, 4: 128-136. 10.1158\/1940-6207.CAPR-10-0163.","journal-title":"Cancer Prev Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-281\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T04:29:47Z","timestamp":1637987387000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2771"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-281","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]},"article-number":"281"}}